Neogen (NEOG) Research & Development (2010 - 2026)
Neogen's (NEOG) quarterly Research & Development came in at $38.2 million in Q1 2026, down 14.35% year-on-year from $44.6 million in Q1 2025, and up 737.17% quarter-over-quarter from $4.6 million in Q4 2025.
Neogen (NEOG) Research & Development (2010 - 2026) Analysis & Trends
Neogen's Research & Development history runs 17 years deep, the most recent figure standing at $38.2 million for Q1 2026.
- On a quarterly basis, Research & Development fell 14.35% year-over-year to $38.2 million in Q1 2026; TTM through Feb 2026 was $94.8 million, a 47.71% decrease from a year earlier, with the FY2025 full-year figure at $183.8 million, up 0.51% from the prior year.
- Research & Development improved to $38.2 million in Q1 2026 per NEOG's latest filing, from $4.6 million in the prior quarter.
- Across five years, Research & Development topped out at $46.9 million in Q2 2025 and bottomed at -$46.2 million in Q2 2022.
- The 5-year median for Research & Development is $38.6 million (2023), against an average of $27.0 million.
- Across the five-year window, Research & Development tumbled 1232.47% in 2022 and soared 819.02% in 2025, its largest moves.
- Year by year, Research & Development stood at $6.8 million in 2022, then surged by 554.86% to $44.8 million in 2023, then increased by 3.82% to $46.5 million in 2024, then plunged by 90.2% to $4.6 million in 2025, then surged by 737.17% to $38.2 million in 2026.
- Per Business Quant, the three latest NEOG Research & Development figures stand at $38.2 million (Q1 2026), $4.6 million (Q4 2025), and $5.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | 38.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 38.20 Mn |
| Nov 30, 2025 | 4.56 Mn |
| Aug 31, 2025 | 5.13 Mn |
| May 31, 2025 | 46.90 Mn |
| Feb 28, 2025 | 44.60 Mn |
| Nov 30, 2024 | 46.55 Mn |
| Aug 31, 2024 | 45.80 Mn |
| May 31, 2024 | 44.34 Mn |
| Feb 29, 2024 | 4.85 Mn |
| Nov 30, 2023 | 44.83 Mn |
| Aug 31, 2023 | 45.78 Mn |
| May 31, 2023 | 42.89 Mn |
| Feb 28, 2023 | 38.60 Mn |
| Nov 30, 2022 | 6.85 Mn |
| Aug 31, 2022 | 23.38 Mn |
| May 31, 2022 | -46.17 Mn |
| Feb 28, 2022 | 21.48 Mn |
| Nov 30, 2021 | 4.33 Mn |
| Aug 31, 2021 | 4.33 Mn |
| May 31, 2021 | 4.08 Mn |